Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2007
11/08/2007WO2007042944A3 Crystal structure of a complex of integron integrase from vibrio cholerae bound to a recombination substrate
11/08/2007WO2007039442A3 Nucleic acid molecules encoding constitutive triple response1-like polypeptides and methods of use thereof
11/08/2007WO2007019331A3 Conjugates of a g-csf moiety and a polymer
11/08/2007WO2007011756A3 Insect chemosensory receptors and methods of use thereof
11/08/2007WO2006116763A3 Lawsonia intracellularis immunological proteins
11/08/2007WO2006059105A8 Non-cytotoxic protein conjugates
11/08/2007WO2005009394A3 Drug delivery in the nervous system
11/08/2007WO2004078785A8 Dispersing agents in nanocomposites
11/08/2007WO2002046458A9 Nucleic acids of the human abca5, abca6, abca9, and abca10 genes, vectors containing such nucleic acids and uses thereof
11/08/2007WO2002046220A9 Sequences upstream of the carp gene, vectors containing them and uses thereof
11/08/2007US20070261138 Synthetase Enzymes
11/08/2007US20070261135 Disease resistance factors
11/08/2007US20070261131 Producing a drought-tolerant transgenic plant; transforming a plant cell with an expression vector comprising a polynucleotide encoding a polypeptide; growing the transformed plant cell to generate transgenic plants; screening
11/08/2007US20070261129 Nucleic acid molecules and other molecules associated with plants
11/08/2007US20070261127 Utilizing light induction to stimulate neuronal cells
11/08/2007US20070260045 vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides
11/08/2007US20070260044 R-alpha1 antitrypsin anion exchange chromatography
11/08/2007US20070260042 Human mast cell-expressed membrane protein (gpcr)
11/08/2007US20070260039 Methods of Producing Silk Polypeptides and Products Thereof
11/08/2007US20070259969 Using CD44 expression profile as diagnostic indicator of cell proliferative disorders
11/08/2007US20070259818 Methods and Compositions for Treating Conditions
11/08/2007US20070259816 Expression vector comprising nucleotide sequences coding homeobox gene for use in identifying modulators for treatment and prevention of nervous system and seizure disorders
11/08/2007US20070259815 Albumin fusion proteins
11/08/2007US20070259813 Anti-Bacterial Composition Especially for Controlling Gram-Negative Bacteria, Comprising a Peptide and an Advantageously Hydrophobic Anti-Bacterial Agent
11/08/2007US20070259809 Methods of Using High Affinity Atiii Variants
11/08/2007US20070259807 Growth Factor HTTER36
11/08/2007US20070259806 Brain-Associated Inhibitor of Tissue-Type Plasminogen Activator
11/08/2007US20070259429 Adenoviral vectors having a protein IX deletion
11/08/2007US20070259422 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
11/08/2007US20070259420 Modulating Photoreactivity in a Cell
11/08/2007US20070259417 Directed evolution of novel binding proteins
11/08/2007US20070259414 Genetic engineering; fusion protein; kits comprising a recombinant vector containing a nucleic acid sequence encoding a UBL molecule selected from the group of SUMO, RUB, HUB, URM1, and ISG15 operably linked to a promoter suitable for expression in the desired host cell
11/08/2007US20070259406 Antimicrobial Compounds
11/08/2007US20070259405 Nucleic acid molecule that is codon-optimized to express beta interferon in Escherichia coli with greater efficacy
11/08/2007US20070259403 Hla-E Chimeric Molecule
11/08/2007US20070259401 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
11/08/2007US20070259400 Antibodies
11/08/2007US20070259399 Novel Liplytic Enzyme Elip
11/08/2007US20070259389 Photoproteins With Enhanced Bioluminescence And Assays Using The Same
11/08/2007US20070259386 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
11/08/2007US20070259383 Novel Genes involved in Epidermal differentiation, and uses thereof
11/08/2007US20070259378 For drug screening; competitive binding; measuring activation by measuring [Ca2+] in the mixture
11/08/2007US20070259373 Identification and modulation of a G-protein coupled receptor (GPCR), RAI3, associated with chronic obstructive pulmonary disease (COPD) and NF-KB and E-selectin regulation
11/08/2007US20070259372 Melanoma differentiation associated gene - 5 and promoter and uses thereof
11/08/2007US20070259358 which promote strand transfer activity of viral integrase, such as HIV integrase; screening molecules for antiviral activity comprising exposing the molecules to epithelial growth factors, fragments or nucleotides codes and determining the ability to modulate the interaction with retroviral integrases
11/08/2007US20070259355 Screening Method for Identifying Pufa Pks in Samples
11/08/2007US20070259342 Lymphoma associated molecules and uses therefor
11/08/2007US20070259341 Prion-Like Form of Cpeb and Related Compositions and Methods
11/08/2007US20070259335 Method for Predicting De Novo Biomacromolecule Crystallization Conditions and for Crystallization of the Same
11/08/2007US20070259334 Preservation of bioactive materials by spray drying
11/08/2007US20070259087 Antimicrobial Peptides
11/08/2007US20070259003 Clostridial toxin derivatives and methods for treating pain
11/08/2007US20070258999 Sars Virus Nucleotide and Amino Acid Sequences and Uses Thereof
11/08/2007US20070258997 Rescue of mumps virus from CDNA
11/08/2007US20070258992 Clostridial peptide for preventing or reducing immunoresistance to botulinum toxin therapy in humans and/or other mammals
11/08/2007US20070258988 Identification and Characterization of Multiple Splice Variants of the Mu Opioid Receptor Gene
11/08/2007US20070258980 Vascular endothelial cell growth factor antagonists and uses thereof
11/08/2007US20070258977 Inhibiting OX-2 (also called CD200) gene expression to treat a tumor that is associated with increased CD200 expression; leukemia; phage display screening for antigens; monoclonal antibodies; fusion proteins; use of OX-2 preventing graft rejection, autoimmune disease, and in inducing tumor cell growth
11/08/2007US20070258962 Plasmid comprising murine cytomegalovirus intermediate early 2 (mCMV-IE2) promoter for enhancing heterologous gene transcription; gene therapy and genetic engineering
11/08/2007US20070258955 Lactobacillus acidophillus nucleic acid sequences encoding cell surface protein homologues and uses therefore
11/08/2007US20070258954 Directed evolution of enzymes and antibodies
11/08/2007US20070258949 Human Cdna Clones Comprising Polynucleotides Encoding Polypeptides and Methods of Their Use
11/08/2007US20070258944 Multiple cytokine protein complexes
11/08/2007US20070258914 casein-derived peptides obtained by hydrolysis of casein by a food grade bacteria containing Lactobacillus helveticusto provide a fermented dairy product containing metalloproteinases inhibitory agent
11/08/2007US20070258895 Estrogen Receptors and Methods of Use
11/08/2007US20070256250 Apparatus And Method For The Selective Assembly Of Protein
11/08/2007DE102006021722A1 Oligonucleotide probes for detecting Erwinia amylovora in a sample by in situ hybridization are complementary to a segment of an Erwinia amylovora 16S ribosomal RNA coding sequence
11/08/2007DE102006020148A1 Gentechnisch hergestelltes Perlucin und seine Verwendung zur Herstellung von Biomaterialien Perlucin genetically engineered and its use for the preparation of biomaterials
11/08/2007DE10054303B4 Analoga, Agonisten, Antagonisten und Varianten der Oxidoreduktase-Enzymaktivität des Makrophagen-Migrations-Inhibitions-Faktors (MIF) als Immunmodulatoren, Therapeutika, Diagnostika und Screening-Agenzien bei inflammatorischen und Immunerkrankungen Analogues, agonists, antagonists, and variants of the oxidoreductase enzyme activity of macrophage migration inhibitory factor (MIF) as immunomodulators, therapeutic agents, diagnostic and screening agents in inflammatory and immune diseases
11/08/2007CA2771087A1 Use of antisecretory factors for treating intraocular hypertension
11/08/2007CA2651062A1 Modelling in yeast of the mitochondrial atp6 gene mutations responsible for narp syndrome in humans and uses thereof for screening for medicaments
11/08/2007CA2650903A1 Antimicrobial linear peptides
11/08/2007CA2650864A1 Peptides modulating the activity of macrophages, useable for the treatment of rheumatoid arthritis
11/08/2007CA2650775A1 Modified metallothioneins and methods for screening and treatment of diseases associated with oxidative stress
11/08/2007CA2650685A1 Method for inducing differentiation of pluripotent stem cells into cardiomyocytes
11/08/2007CA2650485A1 Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation
11/08/2007CA2650473A1 Protein crosslinkers, crosslinking methods and applications thereof
11/08/2007CA2649057A1 Phl p 1 allergen derivative
11/08/2007CA2647985A1 High titer recombinant influenza viruses for vaccines
11/08/2007CA2647815A1 Use of ghrelin splice variant for treating hypercholesterolemia and/or high cholesterol and/or high cholesterol complication and/or lipemia and/or lipemia complication and/or coronary heart disease and/or weight management and/or diabetes and/or hyperglycemia
11/08/2007CA2647812A1 Fusion proteins comprising alpha fetoprotein
11/08/2007CA2647544A1 Covalently-linked complexes of hiv tat and env proteins
11/08/2007CA2647314A1 Pegylated factor viii
11/08/2007CA2646158A1 House dust mite allergen
11/07/2007EP1852509A1 Novel protein promoting carbonic acid fixation and method of fixing carbonic acid by using the protein
11/07/2007EP1852508A2 Actinomycetes polynucleotides
11/07/2007EP1852507A1 CRSP protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor
11/07/2007EP1852505A1 Mutations in ion channels
11/07/2007EP1852445A1 Method for removing solvents from bead polymers
11/07/2007EP1852441A2 Agents that modulate EPH receptor activity
11/07/2007EP1852440A1 Alpha-conotoxin peptides
11/07/2007EP1852126A2 Vaccine for modulating between T1 and T2 immune responses
11/07/2007EP1852125A2 Neisserial vaccine compositions and methods
11/07/2007EP1852124A1 Fibrosis inhibitor for implanted organ
11/07/2007EP1852123A2 Activation and inhibition of the immune system
11/07/2007EP1851553A2 Novel assays utilizing nicotinic acetylcholine receptor subunits
11/07/2007EP1851321A2 Hiv epitopes and pharmaceutical composition containing same
11/07/2007EP1851317A1 Alteration of tobacco alkaloid content through modification of specific cytochrome p450 genes
11/07/2007EP1851315A1 Human antibodies against rabies and uses thereof
11/07/2007EP1851243A2 Epidermal growth factor receptor mutations